Upload Image (Max 20MB per Image)
The US Federal Drug Administration (FDA) has received an application from Sobi for Kineret (anakinra) for the indication of neonatal-onset multisystem inflammatory disease (NOMID). The filing is made under an Orphan Drug Designation for ...
Tags: Nomid Indication, periodic syndromes, clinical trial